Background and Aims: insulinoma is avery rare type of islet cell tumour,but nevertheless the most common endocrine tumour of the pancreas. We aimed at reviewing our clinical experience with this tumour type and to assess whether organ culture could be obtained from surgically resected insulinoma material.
INTRODUCTION
Glucose homeostasis depends on proper function of the pancreatic beta-cell, ahighly specialized cell type secreting insulin in response to nutrients, hormones and neuronal stimuli (1). Impaired function or complete elimination of the beta-cells lead to hyperglycemia and diabetes, which is ac ommon disease with rapidly increasing prevalence. In contrast, some rare disorders arecharacterized by excessive beta-cell activity,and the patients then present with hypoglycemia secondary to elevated and uncontrolled insulin secretion. The clinical pictureinvolves the features of Whipple's triad, which besides the symptoms of hypoglycemia arelow plasma glucose and an immediate relief of symptoms following glucose intake (2). In neonates, elevated insulin levels may be stressinduced, associated with congenital syndromes, or causedb ym utations in at least five genes central in beta-cell metabolism and hormone secretion (3). In adults, af ew cases of hyperinsulinism concurrent with ageneral beta-cell hyperplasia (denoted nesidioblastosis) have been described (4), but abnormal insulin levels areusually indicative of an insulin-secreting tumour.
Although rare, with an annual incidence of one per million, insulinoma is the most common pancreatic endocrine tumour (5). Patients suffering from multiple endocrine neoplasia type 1( MEN-1) have ap redisposition to this tumour form (in addition to tumors of the parathyroid and pituitary glands and to pancreatic gastrinomas) (6). However,t he great majority (90 %) of the insulinoma cases occur sporadic. The female to male ratio is 1.3-1.4 and the median ageatpresentation is about 50 years (7, 8) .Nearly all insulinomas occur within the pancreas wheret hey mayb el ocated in the head, body or tail. Most are small, solitary and benign lesions with adiameter of less than 2c m( 8). When surgical excision has been performed successfully,a round 90% of the patients survive for morethan 10 years (7).
We herereport our experience with insulinoma patients treated at atertiary referral hospital during the last 20 years. Moreover,inlight of the increasing interest in beta-cell biology we have investigated how material from resected human insulinomas may be grown and studied in vitro .
MATERIAL AND METHODS
Allp atients with insulinomas referred to Haukeland University Hospital between 1986 and 2006 werei ncluded in the study.Thereweresix men and ten women, with amedian age of 53 years (range 21-74). One patient had aMEN-1mutation, the other cases wereregarded as sporadic. Two patients had diabetes prior to the diagnosis of insulinoma.
DIAGNOSTIC WORK-UP
Biochemical testing, including a7 2hf asting period, was carried out when hypoglycemic episodes or symptoms suggesting underlying hypoglycemia surfaced (Table 1) (9). Imaging and localization of the tumour werep erformed with intra-operative ultrasonography (IOUS), endoscopic ultrasonography (EUS), CT-scan and/or transcutaneous ultrasonography as found appropriate (10) (11) (12) (13) . Octreoscan or magnetic resonance imaging was performed in some patients. Selective arterial calcium stimulation test with venous sampling (ASVS) and transhepatic selective portal venous sampling (TSPVS)w as done in one patient each (14) .After establishing the diagnosis, medical treatment to control symptoms of hypoglycemia was attempted preoperatively.
OPERATIVE TECHNIqUE
All patients weretreated with laparotomy and enucleation or resection of the tumour.T umor depth, position in the parenchyma and relation to pancreatic ducts and vasculatureweredecisive for selecting resection or enucleation in order to minimize morbidity.T he lesions either abutting the pancreatic duct or larger vessels or growing in an infiltratingmanner wereresected, whereas well-defined, pseudocapsulated and superficially localized insulinomas were enucleated.
ORGAN CULTURE
For all six patients operated after 2000, organ culturew as established from the tumours. Small tissue samples were obtained from the resected tumours and immediately placed in at est tube containing Dulbecco´s Modified Eagle´s Medium (DMEM) (Difco Laboratories, Detroit, MI) supplemented with 10 percent heat-inactivated serum from fetalcalves, four times the prescribed concentration of nonessential aminoa cids, 4m M/mlL -glutamine,p enicillin (100 IU/ml), and streptomycin (100 µg/ml) (= complete DMEM), andbrought to the tissue culturelaboratory.
Tissue samples sized 1-5 mm wereobtained, usually 5-10 from each tumour.The biopsies werewashed three times in complete DMEM medium and then cut with scalpels under adissecting microscope into fragments of about 300 µm in diameter.Fromeach patient an average of 50 tissue fragments wereo btained (range 10-100). Intact fragments without distorting artefacts wereselected under visual control and transferred into 16-mm multiwell dishes (Nunc, Roskilde, Denmark) with one fragment in each well. The wells wereb ase-coated with 0.5 ml of 0.75 %a gar (Agar Noble, Difco Laboratories) in complete DMEM. The overlay suspension was 1.0 ml of complete DMEM which was changed the first time after three days of cultureand thereafter each week. The cultures werem aintained at 37°C in 5% CO 2 and 95% air with 100 %relative humidity.
The size of the fragments was measured weekly during the cultureperiod and recorded as the average sum of the longest diameter and its orthogonal diameter. The measurements wereperformed using aphase-contrast microscope with ac alibrated reticle in the eyepiece. The fragments rounded up as spheroids, and after four weeks in culture, their viability was tested using al ive-dead kit containing calcein-AM and ethidium homodimer,t wo fluorescent probes labelling live and dead cells, respectively (Live/ Dead Viability/Cytotoxicity Assay ;M olecular Probes, Eugene, OR). The tissue fragments werew ashed twice in Dulbecco's phosphate-buffered saline (D-PBS) (Sigma) and incubated individually at room temperaturein16-mm wells containing 0.5 ml of D-PBS with glucose 3mg/ml, calcein-AM 2µ M, and ethidium homodimer 4µ M. Fluorescence was measured using ascanning confocal laser microscope with ak rypton-argon mixed-gas laser (Biorad MRC-1000, HemelE mpstead, UK). As ingle excitation ( λ =4 88 nm) andad ual-emission ( λ =5 22 and 580 nm) measurement was applied via two photomultiplier channels and suitable optical filter sets for simultaneous image acquisition of corresponding fluorescence picturepairs. Live and dead cells weres eparated by having ad istinctive green or red fluorescence, respectively.
LIGHT MICROSCOPy AND IMMUNOSTAINING PROCEDURES
The spheroids were collected by adding human plasma and coagulating with thrombin. The cellular clot was fixed in 10 %formaldehyde. Further processing, including the making of HE-stained sections, was as for routine tissue biopsies. For immunostaining, 4-µm sections weremounted on coated glass slides, deparaffinised in alcohol and xylene, and rehydrated. Epitope retrieval was then performed in tris-EDTAbuffer at pH 9i nam icrowave oven (9 minutes 850 W, 15 minutes 400 W). The slides wereallowed to cool down at room temperaturef or 15 minutes, further cooled in tap water for 5m inutes, and stained using an Autostainer Plus (Dako, Glostrup, Denmark). Primary antibodies wereag uinea pig polyclonal anti-swine insulin antibody at aconcentration of 1:80 (A0564, Dako) and amouse monoclonal anti-human Ki-67 antibody at aconcentration of 1:250 (M7240, Dako). Antibody incubation was carried out at room temperaturefor 45 minutes, followed by blocking in 3%H 2 O 2 .For antibody detection the EnVision polymer system (Dako) was used with diaminobenzidine (DAB plus, Dako) for visualization. Finally,the slides werecounterstained with hematoxylin, dehydrated and mounted.
INSULINASSAy
Insulin was measured by an insulin double-antibody radioimmunoassay kit, based on competition of insulin in a sample with afi xed amount of 125 I-labelled insulin (kit by Pharmacia/Upjohn, Sweden). One hundred µl of conditioned medium from the incubation with insulinoma spheroids and 100 µl of non-incubated complete DMEM (control) werediluted with 400 µl fasting patient serum. Insulin content was measured in triplicates of 50 µl from each diluted sample.
STATISTICS
The statistical analyses wereperformed using the software package Statistica 6.0 (StatSoft TM Inc., Tulsa, OK). Ap-value <0 .05 was chosen for statistical significance. The project was performed according to the declaration of Helsinki and approved by the Regional Committee on Medical Research Ethics.
RESULTS

ESTABLISHMENT OF DIAGNOSIS
The initial symptoms of insulinomas may be insidious. Many of our patients presented with symptoms such as slurred speech, dizziness, dys-coordination, diplopia, headache and hunger.T wo patients experienced stumble and fractureofthe neck of the femur and Colles fracture, respectively.Misinterpretation of the initial symptoms led to diagnostic assumptions of TIA in two, cardiac arrhythmia in one, epileptic seizures in two and diabetes in five. For some patients several years elapsed between the first occurrence of symptoms and the diagnosis of hyperinsulinemic hypoglycemia. Furthermore, for some patients the disease neither presented nor progressed as predicted. Twopatients reflect the intriguing course the disease may take as they were diagnosed with and treated for diabetes for nine and nineteen years, followed by a" no-need" medication free period of 3y ears and 5m onths respectively,beforemanifest symptoms surfaced, workup was done and treatment carried out. One patient lodged what turned out to be amalignant insulinoma with metastasis.
WORK-UP AND SURGERy
Diagnostic work-up demonstrated at umour detection sensitivity of 100%, 73%, and 38% for IOUS, EUS, and CT,r espectively.T he insulinomas werel ocated in all parts of the pancreas (Tables 2a nd 3, Fig. 1 ). They wereall removed by open access surgery,eleven cases by resection and five by enucleation. We found no significant difference in tumour size when located in pancreatic head, body or tail (Table 3 ). Median operating time was 175 min (range 107-250) and peroperative bleeding was 500 ml (range 200-1800).
COMPLICATIONS AND OUTCOME
Immediate rise in blood-glucose levels after tumour resection was recorded in all patients. Eleven patients (69%) had acomplete and uneventful recovery.Four patients experienced pancreas-related complications (three pancreatic juice leak and one bile leak) and one had asystemic complication. The latter patient got a lung embolism one week after he was discharged, was readmitted and received full heparinization without further problems. The bile leak and two of the pancreatic juice leaks dried out gradually and further surgical treatment was not indicated. The thirdpatient suffering from pancreatic juice leak developed apseudo-cyst at the resection brim. He had aw eight-reduction of 14 kg, and was later re-operated with aR oux-en-y conduit from the cyst, after which he graduallyi mproved and recovered completely.
At am ean follow-up of 119m onths, (range: 5 months to 20 years) all but one patient have had no sign of relapse or further need for surgery or oncologic treatment. One patient with an 11-cm malignant insulinoma, who also had liver metastases, experienced increase in size and numbers of the hepatic lesions, and ashift in biochemical secretion products ( Figs 2BC and 3A) . After surgical removal of the primary and regional lymph nodes, the patient needed insulin to control glucose levels, but suffered from secretion of uncharacterized tumour products from the metastasis giving her increased night-sweat and general discomfort. The patient, still alive after more than five years, has been treated with somatostatin, 5-FU, ands treptozotocin withm oderate relief of symptoms.
HISTOPATHOLOGy
Histopathology evaluation demonstrated excision of thirteen benign, two borderline cases, and one malignant insulinoma (Table 4 ).
The borderlinepatients had tumour sizes of 1.0 cm and 2.0 cm, respectively,atendency of diffusegrowth in the periphery of the lesions and aKi-67 proliferation index of 2-5%, but no lymph node involvement. At five and eleven months follow-up, respectively,no recurrence has been observed. The malignant insuli- noma infiltrated the surrounding connective tissue andthe regional lymph nodes and had distant, multifocal metastases in the liver at the time of operation (Fig. 2C ).
IN VITRO CULTIVATION OF HUMAN INSULINOMAS
At the time of explantation, the tissue fragments had ar ough appearance with an uneven, torn periphery. During the first week of culturet he fragments became rounder with as mooth-looking surface covering the whole circumference (Fig. 4 ). This spheroid morphology persisted the rest of the six-week culture period. When explanted, the fragments consisted of an exposed tumour-cell lodging stroma. During the period from two to seven days spheroids emerged (Fig. 4) .The coreofthe fragmentsconsisted of viable tumour cells, connective tissue with vascular elements, and fibroblasts.
After four weeks of incubation, the insulinoma spheroids weret ested with the two vital dyes, calcein-AM and ethidium homodimer.T he tissue was dominated by green-coloured viable cells (Fig. 4) . A few scattered dead cells (red) wereobserved in some of the fragments.
IMMUNOSTAINING AND INSULIN PRODUCTION OF THE SPHEROIDS
All of the six cultured insulinomas werei mmunostained for insulin, and all spheroids from these cases revealed ac learly positive cytoplasmatic staining of the tumour cells (Fig. 4) .The medium in which the spheroids had been cultured, was examined for insulin content. After four weeks of culture, the highest concentration of insulin measured in the medium used was 428 mIU/l, whereas the control medium had an insulin concentration of 0.6 mIU/l.
DISCUSSION
Insulinomas occur rarely and in our study the annual incidence was 0.8 per million (sixteen patients over a twenty year period in ar egion of 940 000 inhabitants), which is close to the incidence of one per million often mentioned in the literature. In general, glucose deprivation of the nervous system leads to am ultiplicity of effects. Vague symp-toms constitute adiagnostic challenge, and once recognized as disease-associated, the symptoms areo ftenm isinterpreted as various other diseases of CNS or cardiac origin, among others. From the CNS, neuroglycopenic symptoms include confusion, loss of consciousness, seizures and blurred vision, whereas from the ANS (autonomic nervous system) the neurogenic symptoms areboth cholinergic (such as hunger and sweating) and adrenergic (such as tremor and palpitations) (15, 16) .
The trigger to selective work-up is very often a measurement of low blood-glucose during or shortly after an episode or "attack". A72-h fast test usually establishes the failureofappropriate insulin suppression in the presence of hypoglycemia and thereby substantiates an autonomously secreting insulinoma lacking feed-back control (Table 1) , (9, 17, 18) .
The large majority of pancreatic tumour patients loose weight rapidly,w hereas for insulinomas the constitutively increased output of insulin often leads to an considerable increased intake of energy-rich fluids and foods to keep serum-glucose within normal range, and asecondary insidious, but significant rise in weight.The mean weight gain in our material was 11 kg. Such hypoglycemia-induced, compensating overeating, to strive for euglycemia, forms the basis for nutritional weight gain in parallel with the anabolic impact boost of constitutive and significantly elevated insulin levels. Av icious circle could be formed by the capacity of the increased body mass to engulf even morenutrients and it is conceivable that even an increased number of insulin receptors will be induced. Furthermore, the weight gain can influence the level of serum-lipids and thereby contribute to increased morbidity.This is an example of biochemical conditioning, leading to an unconscious and customized response and outcome. Unsatisfied with his weight-gain, one male patient was on diet to loose weight and after anormal overnight fast he collapsed during his morning jogging round. This illustrates that exercise can trigger the manifestation of insulinoma, based on the underlying failureofinsulin secretion to fall as aresult of the non-functioning feedback control system of serum-glucose.
Imaging modalities for tumour detection should harbor high resolution capability corresponding to the fact that most insulinomas are less than 2 cm (73% in our material), and that they usually ares ingle lesions. Even though biochemical findings arediagnostic, pre-operative tumour localization of such small lesions calls for highly skilled professionals and supplementary imaging detection modalities (9-11). Intra-operative ultrasound (IOUS) has as ensitivity of 79-100 % according to the literature (10, 11) . However IOUS is done in an optimal setting with simultaneous dedicated and systematic tactile palpation that might contribute to such unmatchable high sensitivity (Fig.  1 , Table 2 ).
Endoscopic ultrasonography (EUS) typically defines awell-circumscribed, hypoechoic, homogeneous nutshell lesion. In experienced hands, EUS stands out as the most sensitive pre-operative modality for localization of insulinomas ( Fig. 1) (10, 11,1 3) . Noteworthy is the fact that CT and EUS came out with incorrect tumour localization in one and two cases respectively (Table 2) , underlining the necessity to exploret he whole pancreas and verify the exact localization by careful multimodal examination of the entireo rgan per-operatively to avoid resections of normal tissue and leaving the insulinoma behind. In our patient series the fact that no pre-operative modality is a1 00% trustworthy was illustrated by one patient who had ab enign cystic lesion taken out in vain beforer e-do was done and the true insulinoma situated in the remnant pancreas identified and resected.
All patients with ad iagnosed insulinoma should be offered surgery,a nd curative therapy of 98% has been reported (19) . The patients in our series were treated with open access surgery.Laparoscopic resection is considered to be safe, but lack of tactile feeling and tumour size and/or suspicion of malignancy might be in favor of open access (20) .
Due to its low incidence and need for specialized work-up neuroendocrine tumours in the pancreas should be treated at aspecialist centre. Even in experienced hands pancreatic resections or enucleations might be hampered with complications that might take multimodal specialist teams and algorithms to handle. For most insulinoma patients long-lasting cureisthe rule, but follow-up in aspecialist center is needed for multifocal lesions, borderline cases and malignantphenotypes. This patient group is furthermoreprone to diabetes post-operatively and therefore in need of adequate follow-up by their GPs and alow threshold for referrals.
Generally,cell lines develop genotypical and phenotypical changesd eparting them from both the original environmental influence and the immanent biochemical faculty they once had. To maintain human insulinoma cell lines in vitro ,thereisreported an essential need to add both fibroblasts and other additives, as for instance growth factors, to securecontinuous secretion capability and to avoid degeneration and apoptosis (21) . In addition, these supplementations and the fibroblasts used often cross the species immune barrier,a lthough xenografts are known to be moreprone to malfunction and rejection than auto-transplants. In our model system, insulinoma cell spheroids are co-cultured with immune-matching connective tissue components in the harbored stroma from as ingle parent organ, which is morel ikely to mimic the in vivo architecture ( Fig. 4) . Furthermore, this model keeps open the possibilities for cellular by-stander and stromal crosstalk through insulinoma-insulinoma and fibroblast-insulinoma cell interactions. Finally, the non-adhesive spheroid technique prevent fibroblast overgrowth which is acommon problem in cell line cultures. By this study we have shown that it is possible to initiate and maintain spheroids with intact insulin secretion from insulinoma tumors in organ culturefor at least six weeks.
In conclusion, our non-adhesive spheroid model yields abetter goodness-of-fit to the in vivo situation, than do human 2-D insulinoma cell lines kept alive by xenograft fibroblast and different, often rodentderived additives. Furthermore, from ap ractical standpoint of view,t he non-adhesiveness of the spheroids makes them easier to handle and maintain than2 -D cell lines. For these reasons, the described non-adhesive organ cultures ystem offers as imple tool for unique biological studies on insulinomas, which again may yield new knowledge about the pancreatic beta-cells and their diseases.
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